Board of Directors

Richard Mead is a Senior Lecturer (associate professor) at the Sheffield Institute for Translational Neuroscience. He has extensive experience in preclinical drug discovery in academia and industry with a track record of taking compounds through preclinical programs to nomination for clinical development. He has previously identified an electrophilic Nrf2 activator which obtained orphan designation with the EMA for MND. He is a named inventor on 38 patents in 5 families, has authored 20 scientific publications and raised funding of £9M as primary investigator and founder.

Ross McMaster is financial consultant at Sheffield University Enterprises Ltd (Suel). A Fellow of the Association of Chartered Certified Accountants with a BA [Hons] in Accounting and Business, Ross specialises in the provision of management accounting services, strategic and business planning, financial forecasting and statutory accounts preparation for SMEs.

During his time at Suel, Ross has been involved in a variety of fundraising transactions for private limited companies. He also provides corporate governance guidance whilst holding the position of company secretary to a number of companies spun out from the University of Sheffield.

Arthur Roach is Director of Research at Parkinson’s UK. Before joining Parkinson’s UK Arthur held several academic and industrial positions, most recently as Senior Director, Neurodegenerative Diseases Research at Merck Serono. He is also a founder and Head of the SAB of the Swiss-based biotech Chord Therapeutics.